Clinical Trial Update: A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial of bermekimab for adult atopic dermatitis was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• bermekimab (bermekimab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Dermatitis, Atopic | Phase 2 | Status: TERMINATED | Results posted: 2023-05-24